Enterprise Value
22.8M
Cash
205.4M
Avg Qtr Burn
-56.08M
Short % of Float
14.85%
Insider Ownership
1.63%
Institutional Own.
-
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Tab-cel (tabelecleucel) Details Viral infection, Epstein-Barr virus, Nasopharyngeal carcinoma, Solid organ transplant, Hematopoietic cell transplantation | BLA Submission | |
Phase 2 Data readout |